Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing
暂无分享,去创建一个
Dian Yang | Seung K. Kim | Jing Wang | C. Dudgeon | D. Carpizo | M. Winslow | Grace E. Kim | Chen-Hua Chuang | Jennifer J. Brady | B. Grüner | S. Chiou | F. Tamburini | P. Chu | H. Zeng | S. Naranjo | D. Caswell | I. Winters | Pauline Chu
[1] L. Wood,et al. RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma , 2015, Cell.
[2] J. Kench,et al. Whole genomes redefine the mutational landscape of pancreatic cancer , 2015, Nature.
[3] S. Kalghatgi,et al. Pancreatic Cancer in Chronic Pancreatitis , 2015, Indian Journal of Surgical Oncology.
[4] M. Hebrok,et al. Plasticity and dedifferentiation within the pancreas: development, homeostasis, and disease. , 2015, Cell stem cell.
[5] Joana A. Vidigal,et al. In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system , 2014, Nature.
[6] Robert Langer,et al. CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling , 2014, Cell.
[7] B. Boulay,et al. Managing malignant biliary obstruction in pancreas cancer: choosing the appropriate strategy. , 2014, World journal of gastroenterology.
[8] Benjamin D. Smith,et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.
[9] Dian Yang,et al. Obligate progression precedes lung adenocarcinoma dissemination. , 2014, Cancer discovery.
[10] A. Berns,et al. Multiple cells-of-origin of mutant K-Ras–induced mouse lung adenocarcinoma , 2014, Proceedings of the National Academy of Sciences.
[11] C. Cordon-Cardo,et al. RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis. , 2014, Cancer discovery.
[12] S. Lowe,et al. A modular and flexible ESC-based mouse model of pancreatic cancer , 2014, Genes & development.
[13] I. Mellman,et al. Lkb1 regulates organogenesis and early oncogenesis along AMPK-dependent and -independent pathways , 2012, The Journal of cell biology.
[14] K. Jensen,et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.
[15] Lincoln D. Stein,et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.
[16] T. Jacks,et al. Expression of tumour-specific antigens underlies cancer immunoediting , 2011, Nature.
[17] A. Berns,et al. Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung. , 2011, Cancer cell.
[18] Liqun Luo,et al. Site-specific integrase-mediated transgenesis in mice via pronuclear injection , 2011, Proceedings of the National Academy of Sciences.
[19] S. Morrison,et al. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells , 2010, Nature.
[20] A. Ashworth,et al. LKB1 Haploinsufficiency Cooperates With Kras to Promote Pancreatic Cancer Through Suppression of p21-Dependent Growth Arrest , 2010, Gastroenterology.
[21] P. Maisonneuve,et al. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. , 2010, Best practice & research. Clinical gastroenterology.
[22] E. Kruse,et al. Palliation in pancreatic cancer. , 2010, The Surgical clinics of North America.
[23] Allan R. Jones,et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.
[24] Gerald C. Chu,et al. Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. , 2009, Cancer cell.
[25] S. Yachida,et al. The pathology and genetics of metastatic pancreatic cancer. , 2009, Archives of pathology & laboratory medicine.
[26] C. Cordon-Cardo,et al. Inactivation of p53 and Pten promotes invasive bladder cancer. , 2009, Genes & development.
[27] C. Cordon-Cardo,et al. Inactivation of p 53 and Pten promotes invasive bladder cancer , 2009 .
[28] G. Feldmann,et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice , 2008, Proceedings of the National Academy of Sciences.
[29] Gerald C. Chu,et al. Pancreatic Lkb1 Deletion Leads to Acinar Polarity Defects and Cystic Neoplasms , 2008, Molecular and Cellular Biology.
[30] Jan Grimm,et al. A spatially and temporally restricted mouse model of soft tissue sarcoma , 2007, Nature Medicine.
[31] M. Barbacid,et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. , 2007, Cancer cell.
[32] Gerald C. Chu,et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. , 2006, Genes & development.
[33] Ralph Weissleder,et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[34] Simon C Watkins,et al. Widespread and stable pancreatic gene transfer by adeno-associated virus vectors via different routes. , 2006, Diabetes.
[35] R. Hruban,et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.
[36] T. Jacks,et al. Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome , 2004, Cell.
[37] S. Ashley,et al. Palliation for pancreatic cancer , 1996, Surgical Endoscopy.
[38] R. DePinho,et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.
[39] E. Petricoin,et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.
[40] T. Ogihara,et al. β-cell neogenesis induced by adenovirus-mediated gene delivery of transcription factor pdx-1 into mouse pancreas , 2003, Gene Therapy.
[41] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[42] A. Berns,et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer , 2001, Nature Genetics.
[43] R. Hruban,et al. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. , 1999, The American journal of pathology.
[44] K. Rajewsky,et al. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. , 1995, Nucleic acids research.
[45] I. Mellman,et al. Lkb1 regulates organogenesis and early oncogenesis along AMPK-dependent and -independent pathways , 2012, The Journal of cell biology.